Undetermined stroke genesis and hidden cardiomyopathies determined by cardiac magnetic resonance

Neurology ◽  
2019 ◽  
Vol 94 (1) ◽  
pp. e107-e113 ◽  
Author(s):  
Ana Catarina Fonseca ◽  
João Pedro Marto ◽  
Daniela Pimenta ◽  
Tatiana Guimarães ◽  
Pedro N. Alves ◽  
...  

ObjectiveTo determine whether cardiac magnetic resonance imaging (CMR) could be useful in identifying previously undiagnosed cardiomyopathies in a cohort of patients with ischemic stroke who underwent standard etiologic investigation and to describe the type and frequency of these cardiomyopathies.MethodsWe performed a subanalysis of a previously collected prospective cohort of patients with ischemic stroke. Patients with structural changes on echocardiography that are considered causal for stroke in the Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification were excluded. A 3T CMR was performed. We compared the frequency of the cardiomyopathies that we found with reference values for the general population.ResultsOne hundred thirty-two patients with a mean age of 68.4 years were included. In 7 patients (5.3%, 95% confidence interval 2.59%–10.54%) CMR identified cardiomyopathy. Four patients had hypertrophic cardiomyopathy, 2 had restrictive cardiomyopathy, and 1 had noncompaction cardiomyopathy. Six of these patients had been classified after standard evaluation as having undetermined stroke and 1 patient as having cardioembolic stroke (atrial fibrillation). We found a higher frequency of hypertrophic cardiomyopathy in the entire cohort and in the undetermined cause group compared to the general population (3.03% and 5.81% vs 0.2%, respectively, p = 0.001 and p < 0.001). The frequency of noncompaction cardiomyopathy was also higher in our cohort (0.76% vs 0.05%, respectively, p < 0.001).ConclusionsAlthough rare, cardiomyopathies should be considered as a possible cause of ischemic stroke classified as of undetermined etiology after standard evaluation.

2021 ◽  
Vol 2021 ◽  
pp. 1-5
Author(s):  
Nathan Zaher ◽  
Hammam Shereef ◽  
Rashid Al Hussain ◽  
John Dawdy ◽  
Diane Levine ◽  
...  

Apical Hypertrophic Cardiomyopathy (ApHCM) is a rare variant of hypertrophic cardiomyopathy with a low prevalence in the general population. ApHCM with right ventricular involvement (BiApHCM) is largely unreported and may not be detected with conventional transthoracic echocardiogram (TTE) alone. Cardiac Magnetic Resonance (CMR) has been demonstrated to be a proficient imaging modality to diagnose BiApHCM. We present a case of BiApHCM that was diagnosed with TTE and further characterized by CMR. This imaging modality may be utilized more in the future to help diagnose and detect the prevalence of BiApHCM.


Author(s):  
Zsofia Dohy ◽  
Liliana Szabo ◽  
Attila Toth ◽  
Csilla Czimbalmos ◽  
Rebeka Horvath ◽  
...  

AbstractThe prognosis of patients with hypertrophic cardiomyopathy (HCM) varies greatly. Cardiac magnetic resonance (CMR) is the gold standard method for assessing left ventricular (LV) mass and volumes. Myocardial fibrosis can be noninvasively detected using CMR. Moreover, feature-tracking (FT) strain analysis provides information about LV deformation. We aimed to investigate the prognostic significance of standard CMR parameters, myocardial fibrosis, and LV strain parameters in HCM patients. We investigated 187 HCM patients who underwent CMR with late gadolinium enhancement and were followed up. LV mass (LVM) was evaluated with the exclusion and inclusion of the trabeculae and papillary muscles (TPM). Global LV strain parameters and mechanical dispersion (MD) were calculated. Myocardial fibrosis was quantified. The combined endpoint of our study was all-cause mortality, heart transplantation, malignant ventricular arrhythmias and appropriate implantable cardioverter defibrillator (ICD) therapy. The arrhythmia endpoint was malignant ventricular arrhythmias and appropriate ICD therapy. The LVM index (LVMi) was an independent CMR predictor of the combined endpoint independent of the quantification method (p < 0.01). The univariate predictors of the combined endpoint were LVMi, global longitudinal (GLS) and radial strain and longitudinal MD (MDL). The univariate predictors of arrhythmia events included LVMi and myocardial fibrosis. More pronounced LV hypertrophy was associated with impaired GLS and increased MDL. More extensive myocardial fibrosis correlated with impaired GLS (p < 0.001). LVMi was an independent CMR predictor of major events, and myocardial fibrosis predicted arrhythmia events in HCM patients. FT strain analysis provided additional information for risk stratification in HCM patients.


2009 ◽  
Vol 54 (3) ◽  
pp. 242-249 ◽  
Author(s):  
Deborah H. Kwon ◽  
Nicholas G. Smedira ◽  
E. Rene Rodriguez ◽  
Carmela Tan ◽  
Randolph Setser ◽  
...  

Heart ◽  
2015 ◽  
Vol 101 (11) ◽  
pp. 870-876 ◽  
Author(s):  
Hong-Mi Choi ◽  
Kyung-Hee Kim ◽  
Joo Myung Lee ◽  
Yeonyee E Yoon ◽  
Seung-Pyo Lee ◽  
...  

2011 ◽  
Vol 27 (Supplement) ◽  
pp. PE3_005
Author(s):  
Xiao-Hui Ning ◽  
Min Tang ◽  
Ke-Ping Chen ◽  
Wei Hua ◽  
Ruo-Han Chen ◽  
...  

Biomarkers ◽  
2018 ◽  
Vol 23 (7) ◽  
pp. 676-682 ◽  
Author(s):  
Monika Gawor ◽  
Mateusz Śpiewak ◽  
Agata Kubik ◽  
Aleksandra Wróbel ◽  
Anna Lutyńska ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document